Market Recap Check: Abbvie Inc (ABBV)’s Negative Finish at 160.45, Up/Down -1.29

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

The price of Abbvie Inc (NYSE: ABBV) closed at $160.45 in the last session, down -1.29% from day before closing price of $162.55. In other words, the price has decreased by -$1.29 from its previous closing price. On the day, 5.8 million shares were traded. ABBV stock price reached its highest trading level at $162.9 during the session, while it also had its lowest trading level at $159.87.


We take a closer look at ABBV’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.68 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.97. For the most recent quarter (mrq), Quick Ratio is recorded 0.83 and its Current Ratio is at 0.94. In the meantime, Its Debt-to-Equity ratio is 9.24 whereas as Long-Term Debt/Eq ratio is at 7.97.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 20 ’24 when Donoghoe Nicholas sold 21,082 shares for $176.30 per share. The transaction valued at 3,716,757 led to the insider holds 55,903 shares of the business.

Stewart Jeffrey Ryan sold 58,949 shares of ABBV for $10,539,508 on Mar 18 ’24. The EVP, CHIEF COMMERCIAL OFFICER now owns 60,941 shares after completing the transaction at $178.79 per share. On Mar 01 ’24, another insider, RICHMOND TIMOTHY J., who serves as the EVP, CHIEF HR OFFICER of the company, sold 75,680 shares for $177.27 each. As a result, the insider received 13,415,503 and left with 13,837 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABBV now has a Market Capitalization of 283333820416 and an Enterprise Value of 343371808768. As of this moment, Abbvie’s Price-to-Earnings (P/E) ratio for their current fiscal year is 47.77, and their Forward P/E ratio for the next fiscal year is 13.32. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 7.84. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.21 while its Price-to-Book (P/B) ratio in mrq is 35.38. Its current Enterprise Value per Revenue stands at 6.312 whereas that against EBITDA is 13.381.

Stock Price History:

Over the past 52 weeks, ABBV has reached a high of $182.89, while it has fallen to a 52-week low of $130.96. The 50-Day Moving Average of the stock is -6.95%, while the 200-Day Moving Average is calculated to be 1.76%.

Shares Statistics:

According to the various share statistics, ABBV traded on average about 5.69M shares per day over the past 3-months and 6007020 shares per day over the past 10 days. A total of 1.77B shares are outstanding, with a floating share count of 1.76B. Insiders hold about 0.12% of the company’s shares, while institutions hold 71.76% stake in the company. Shares short for ABBV as of 1713139200 were 13536080 with a Short Ratio of 2.38, compared to 1710460800 on 14691308. Therefore, it implies a Short% of Shares Outstanding of 13536080 and a Short% of Float of 0.77.

Dividends & Splits

The forward annual dividend rate for ABBV is 6.06, which was 6.06 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.037280835The stock’s 5-year Average Dividend Yield is 4.4.

Most Popular

[the_ad id="945"]